Enclomiphene vs Clomid: The Isomer Difference
Men have been prescribed clomiphene — Clomid — for low testosterone for decades, off-label, on the strength of a mechanism that works and a price that is hard to argue with. Enclomiphene is the same idea with one thing removed. This page is about what was removed, why it matters, and the odd regulatory position that leaves the cruder drug approved and the refined one compounded.
It is a page about a molecule, not about coming off testosterone. If you arrived here looking for a restart protocol, this is not it, and we do not write them.
Clomiphene is a mixture
Clomiphene citrate is not one molecule. It is two — geometric isomers, mirror-arrangements of the same atoms — in a fixed ratio of roughly 62% enclomiphene to 38% zuclomiphene. The pill has been that mixture since 1967, because that is how the synthesis comes out and nobody separated them for the original purpose, which was inducing ovulation in women.
The two isomers do not behave the same way.
Enclomiphene is the trans isomer. It blocks estrogen receptors in the hypothalamus and pituitary, which removes estrogen's braking signal and lets the pituitary release more LH and FSH. In a man, that means the testes are told to make more testosterone — and more sperm. It clears the body in about a day.
Zuclomiphene is the cis isomer. It has weak estrogenic activity rather than anti-estrogenic, contributes little to the testosterone rise, and has a half-life measured in weeks rather than hours. Take clomiphene daily and zuclomiphene accumulates; stop it, and zuclomiphene is still circulating a month later.
That accumulation is where clomiphene's characteristic side effects in men are thought to come from: the mood changes, the visual disturbances, the estrogenic effects that have to be managed, and the sense some men describe of feeling "off" on a drug that is nonetheless raising their testosterone.
Enclomiphene is the useful half, alone
Enclomiphene as a single agent was developed under the name Androxal specifically for secondary hypogonadism in men. In its phase 3 trials it raised testosterone into the normal range in most men while maintaining or increasing sperm concentration — the opposite of what testosterone replacement does to sperm, which is the subject of the fertility page.
Because zuclomiphene is absent, there is nothing to accumulate. The estrogenic side effects of the mixture are reduced, and the drug is gone from the body quickly when stopped.
The regulatory inversion
Here is the odd part. Clomiphene is FDA-approved — for ovulation induction in women — and is prescribed to men off-label. Enclomiphene, the purified active isomer, was not approved: the FDA issued a complete response letter in 2015, on grounds relating to trial design and the definition of the condition rather than to safety, and the developer did not resubmit.
So the approved product is the mixture, and the refined isomer is available only compounded. The main page covers what that means in practice. It is a legitimate use of compounding — a formulation that differs meaningfully from any approved product — and it is also a product without an FDA label, which is a fact we state rather than bury.
Which one, and when
For a man whose testosterone is low because the signal from the pituitary is weak — secondary hypogonadism — either drug can restore the signal. Enclomiphene does it with fewer of the effects attributable to the other isomer, which is why we carry it rather than clomiphene.
Neither drug works when the problem is in the testes rather than the pituitary. Neither is testosterone replacement, and neither is a route to it or from it: the decision between stimulating your own production and replacing it is on the men's TRT page, and it is made on labs and history, not on preference for a pill over an injection.
Frequently asked questions
No. Clomid is a mixture of two isomers; enclomiphene is the one that raises testosterone, without the long-lived estrogenic isomer zuclomiphene.
Those effects are generally attributed to zuclomiphene, which accumulates with daily use and lingers for weeks after stopping.
No. It received a complete response letter in 2015 and is available compounded. Clomiphene is approved for ovulation induction in women and used off-label in men.
It produces a comparable testosterone rise with fewer of the effects attributed to zuclomiphene. Head-to-head trials in men are limited.
That is not a question this site answers, and not a use we prescribe for. See the men's TRT page for how the replacement-versus-stimulation decision is made.
It generally preserves or improves sperm production, unlike testosterone replacement. See the fertility page.
Where this fits in your plan
The Enclomiphene ODT page covers the product; primary vs secondary low testosterone covers whether it can work for you at all. A baseline panel including LH and FSH comes first.
We measure first. Then we act.
References
- Wiehle RD et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertility and Sterility 2014;102:720–727.
- Kim ED et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU International 2016;117:677–685.
- Earl JA, Kim ED. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert Opinion on Pharmacotherapy 2019;20:1747–1754.
- Clomid (clomiphene citrate) prescribing information — isomer composition and pharmacokinetics.
- FDA complete response letter, Androxal (enclomiphene citrate) NDA, 2015.
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.